1 Product identity
Ingredient risk
1 ingredient to use with caution
Boswellia Extract 250 mg
BrandDC→Botanical with Nutrients Capsule 6 ingredients 1 caution DSLD #309841Net contents: 100 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2024-03-22
2 Ingredients (6)
IngredientGroupSafety
Boswellic AcidsBoswellic acids—
GelatinGelatin—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Boswellia — Generally Safe
⚠ GI discomfort
⚠ May enhance anticoagulants
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID309841
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2024-03-22
6 More from DC
View DC Safety Scorecard → 66 products
Beta GlucanBioChroMateC-250 Chewable Orange-FlavoredCalcium 600 with DCalcium 600 with DCalcium 600 with D7 Cite this page
Vancouver
Pkhakadze G. Boswellia Extract 250 mg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jun 24]. Available from: https://supplement.ge/products/boswellia-extract-250-mg-309841/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG